![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | estrogen receptors, 188-89, 191-92, 207, 247-48
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | generated in ovulatory cycle, 167-68, 187
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | global consumption of, 186-92
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | isolation of and research on, 183-84
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | male vs. female levels of, 185
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | phytoestrogens, 181, 212
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | post-pregnancy, 148
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | replacement therapy, 60, 184, 185, 231, 233
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | for AlS, 32
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | and blood clots, 189
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | debate over, 185, 207-15
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | medical promotion of, 220
|
![](/files/02/66/56/f026656/public/2ef551086588a968abff1b9f23537cb8.gif) | resistance to, 191
|
|